GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Microbix Biosystems MBX.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

0.29

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$18.6m

FY2016FY2025

Net income

−C$2.2m

FY2016FY2025

Free cash flow

−C$877,580

FY2016FY2025

Shareholders' equity

C$27.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$18.6mC$25.4mC$16.5mC$19.1mC$18.6mC$10.5mC$13.4mC$12.5mC$10.2mC$9.5m
Gross profitC$9.9mC$15.4mC$7.5mC$11.1mC$11.0mC$4.7mC$6.5mC$5.4mC$4.8mC$5.0m
Research and developmentC$2.3mC$2.1mC$2.0mC$1.8mC$1.0mC$1.0mC$1.0mC$1.1mC$994,584C$493,610
Operating income−C$1.7mC$3.9mC$799,895C$2.7mC$4.8m−C$524,601C$1.1m−C$7.8m−C$3.3mC$839,044
Net income−C$2.2mC$3.5m−C$39,483C$1.8mC$1.6m−C$6.2mC$31,918−C$8.6m−C$3.8mC$748,407
Diluted earnings per share-0.020.03-0.000.010.01-0.060.00-0.09-0.040.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$37.4mC$38.1mC$35.7mC$33.1mC$28.8mC$15.6mC$19.6mC$19.3mC$26.4mC$25.2m
Cash and short-term investmentsC$12.1mC$13.0mC$11.6mC$13.5mC$10.0mC$92,661C$95,571C$44,358C$54,460C$5,415
Total liabilitiesC$9.6mC$9.8mC$11.0mC$8.2mC$10.3mC$9.0mC$9.1mC$9.0mC$11.3mC$10.0m
DebtC$6.8mC$6.4mC$6.6mC$5.8mC$7.7mC$6.2mC$7.0mC$6.3mC$7.3mC$7.4m
Shareholders' equityC$27.8mC$28.3mC$24.6mC$24.9mC$18.6mC$6.6mC$10.5mC$10.4mC$15.2mC$15.3m
Shares outstanding139m136m138m139m147m109m97m97m97m85m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−C$80,287C$4.3m−C$1.1mC$3.5mC$2.1mC$8,566C$44,368−C$537,005C$297,047C$913,308
Capital spending−C$797,293−C$1.9m−C$1.0m−C$2.0m−C$1.3m−C$813,908−C$514,800−C$1.2m−C$640,750−C$1.6m
Free cash flow−C$877,580C$2.4m−C$2.1mC$1.4mC$804,197−C$805,342−C$470,432−C$1.8m−C$343,703−C$727,818

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$4.1mC$3.4mC$4.2mC$3.7mC$3.5mC$5.3mC$6.0mC$6.3m
Gross profitC$2.2mC$1.6mC$1.7mC$1.5mC$1.4mC$3.2mC$3.8mC$3.5m
Operating income−C$658,182−C$1.3m−C$949,194−C$1.4m−C$1.5mC$271,889C$970,091C$710,778
Net income−C$806,762−C$1.4m−C$1.2m−C$1.5m−C$1.6mC$20,664C$856,962C$440,324
Diluted earnings per share-0.01-0.01-0.01-0.01-0.010.000.010.00
Cash from operations——−C$2.0m—−C$1.0m———
Total assetsC$34.1mC$35.4mC$36.6mC$37.4mC$38.3mC$39.4mC$39.3mC$38.1m
Cash and short-term investmentsC$7.2mC$8.1mC$9.1mC$12.1mC$12.1mC$14.5mC$13.0mC$13.0m
DebtC$5.6mC$5.6mC$6.9mC$6.8mC$6.4mC$5.4mC$6.4mC$6.4m
Shareholders' equityC$24.3mC$25.1mC$26.6mC$27.8mC$29.3mC$31.1mC$28.9mC$28.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.9%12.0%7.7%
Operating income—26.6%—
Net income—-18.5%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin57.4%55.1%54.8%53.4%
Operating margin5.0%7.2%9.2%0.8%
Net margin2.9%3.8%-1.4%-7.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-14.215.8-1359.131.874.7-7.4—-2.6-7.828.9
Price to sales1.72.23.33.06.54.41.81.82.92.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.